A new trading day began on Monday, with Evolus Inc (NASDAQ: EOLS) stock price up 7.65% from the previous day of trading, before settling in for the closing price of $9.54. EOLS’s price has ranged from $8.67 to $17.82 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 51.00%. Meanwhile, its annual earnings per share averaged 36.89%. With a float of $56.11 million, this company’s outstanding shares have now reached $63.50 million.
Let’s determine the extent of company efficiency that accounts for 332 employees. In terms of profitability, gross margin is 67.4%, operating margin of -11.73%, and the pretax margin is -18.69%.
Evolus Inc (EOLS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Evolus Inc is 11.76%, while institutional ownership is 81.98%. The most recent insider transaction that took place on Mar 27 ’25, was worth 77,512. In this transaction an insider of this company sold 6,251 shares at a rate of $12.40, taking the stock ownership to the 508,619 shares. Before that another transaction happened on Mar 18 ’25, when Company’s insider sold 27,904 for $13.26, making the entire transaction worth $369,868. This insider now owns 362,467 shares in total.
Evolus Inc (EOLS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 36.89% per share during the next fiscal year.
Evolus Inc (NASDAQ: EOLS) Trading Performance Indicators
Here are Evolus Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach 0.65 in one year’s time.
Technical Analysis of Evolus Inc (EOLS)
Looking closely at Evolus Inc (NASDAQ: EOLS), its last 5-days average volume was 1.55 million, which is a jump from its year-to-date volume of 0.87 million. As of the previous 9 days, the stock’s Stochastic %D was 27.86%. Additionally, its Average True Range was 0.91.
During the past 100 days, Evolus Inc’s (EOLS) raw stochastic average was set at 18.93%, which indicates a significant decrease from 41.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 87.25% in the past 14 days, which was higher than the 68.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.95, while its 200-day Moving Average is $13.53. However, in the short run, Evolus Inc’s stock first resistance to watch stands at $10.70. Second resistance stands at $11.13. The third major resistance level sits at $11.76. If the price goes on to break the first support level at $9.65, it is likely to go to the next support level at $9.02. Should the price break the second support level, the third support level stands at $8.59.
Evolus Inc (NASDAQ: EOLS) Key Stats
With a market capitalization of 653.07 million, the company has a total of 63,587K Shares Outstanding. Currently, annual sales are 266,270 K while annual income is -50,420 K. The company’s previous quarter sales were 78,950 K while its latest quarter income was -6,790 K.
